Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00380679
Recruitment Status : Unknown
Verified September 2006 by Louisiana State University Health Sciences Center in New Orleans.
Recruitment status was:  Active, not recruiting
First Posted : September 26, 2006
Last Update Posted : September 26, 2006
Sponsor:
Collaborator:
Centers for Disease Control and Prevention
Information provided by:
Louisiana State University Health Sciences Center in New Orleans

Brief Summary:

According to the Advisory Committee on Immunization Practices (ACIP), all people aged 50 years or older and persons aged less than 50 years who have medical conditions that put them at increased risk for serious influenza disease should receive an annual influenza vaccination. However, since the mid-1990s, vaccination rates and racial disparities have mostly remained static, and there has been limited progress towards the Healthy People 2010 objectives for influenza vaccination coverage.

The purpose of this study is to determine what proportion of previously unvaccinated persons in target groups for whom influenza and pneumococcal vaccine are recommended will accept and receive influenza and/or pneumococcal vaccine in an urban emergency department (ED), and to estimate the potential impact of ED vaccination on population-based vaccination coverage. The intervention will utilize a combination of assessment survey, vaccine information and pre-printed vaccine order sheets.

The target population for influenza vaccinations includes all patients aged 18 years and older for whom influenza vaccine is recommended by the ACIP. This includes all persons aged 50 years and older and persons aged 18 to 49 years who are in one of the following groups: 1) health care workers, 2) pregnant women, 3) residents of long-term care facilities, 4) household contacts and out-of-home caregivers of children aged 0 to 23 months, or 5) persons with underlying chronic medical conditions which increase their risk of influenza-related complications. The target population for pneumococcal vaccination includes all patients aged 65 years or older who have not previously been vaccinated against pneumococcus or have not received the vaccine within 5 years (and were less than 65 years at the time of vaccination).


Condition or disease Intervention/treatment Phase
High Risk for Serious Influenza High Risk for Pneumonia Biological: Influenza vaccination Biological: Pneumococcal polysaccharide vaccination Phase 2

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department
Study Start Date : December 2005
Study Completion Date : March 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Flu Flu Shot




Primary Outcome Measures :
  1. Acceptance of vaccinations
  2. Receipt of vaccination

Secondary Outcome Measures :
  1. Reasons vaccines were refused
  2. Reasons vaccines were not administered


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Baton Rouge General Medical Center

Inclusion Criteria:

  • Patients aged 18 years and older who are seeking medical care in the ED

Exclusion Criteria:

  • All patients under 18 years of age will be excluded. Any patient with a medically unstable condition, altered mental status, or language barrier will also be excluded. Patients who present with a contraindication to influenza vaccination (acute febrile illness or a history of allergic reaction to eggs) or pneumococcal vaccine will not be eligible for receipt of those vaccines.

Our Lady of the Lake Regional Medical Center

Inclusion Criteria:

  • Patients aged 50 years and older who are seeking medical care in the ED

Exclusion Criteria:

  • All patients under 50 years of age will be excluded. Any patient with a medically unstable condition, altered mental status, or language barrier will also be excluded. Patients who present with a contraindication to influenza vaccination (acute febrile illness or a history of allergic reaction to eggs) or pneumococcal vaccine will not be eligible for receipt of those vaccines

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00380679


Locations
Layout table for location information
United States, Louisiana
Baton Rouge General Medical Center
Baton Rouge, Louisiana, United States, 70806
Our Lady of the Lake Regional Medical Center
Baton Rouge, Louisiana, United States, 70808
Sponsors and Collaborators
Louisiana State University Health Sciences Center in New Orleans
Centers for Disease Control and Prevention
Investigators
Layout table for investigator information
Principal Investigator: William M Cassidy, MD Louisiana State University Health Sciences Center
Principal Investigator: Daniel Fishbein, MD Centers for Disease Control and Prevention
Publications:
National Center for Health Statistics. Health, United States, 2004 with chartbook on trends in the health of Americans. 2004. Hyattsville, MD, National Center for Health Statistics. Ref Type: Report
American College of Emergency Physicians. Immunization of adult patients. 2000. Ref Type: Report

Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00380679    
Other Study ID Numbers: 5800
First Posted: September 26, 2006    Key Record Dates
Last Update Posted: September 26, 2006
Last Verified: September 2006
Additional relevant MeSH terms:
Layout table for MeSH terms
Influenza, Human
Pneumonia
Emergencies
Orthomyxoviridae Infections
RNA Virus Infections
Virus Diseases
Respiratory Tract Infections
Respiratory Tract Diseases
Disease Attributes
Pathologic Processes
Lung Diseases
Vaccines
Immunologic Factors
Physiological Effects of Drugs